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The State of US Health, 1990-2016
Burden of Diseases, Injuries, and Risk Factors Among US States
The US Burden of Disease Collaborators
INTRODUCTION Several studies have measured health outcomes in the United States, but
none have provided a comprehensive assessment of patterns of health by state.
OBJECTIVE To use the results of the Global Burden of Disease Study (GBD) to report trends in
the burden of diseases, injuries, and risk factors at the state level from 1990 to 2016.
DESIGN AND SETTING A systematic analysis of published studies and available data sources
estimates the burden of disease by age, sex, geography, and year.
MAIN OUTCOMES AND MEASURES Prevalence, incidence, mortality, life expectancy, healthy
life expectancy (HALE), years of life lost (YLLs) due to premature mortality, years lived with
disability (YLDs), and disability-adjusted life-years (DALYs) for 333 causes and 84 risk factors
with 95% uncertainty intervals (UIs) were computed.
RESULTS Between 1990 and 2016, overall death rates in the United States declined from
745.2 (95% UI, 740.6 to 749.8) per 100 000 persons to 578.0 (95% UI, 569.4 to 587.1) per
100 000 persons. The probability of death among adults aged 20 to 55 years declined in 31
states and Washington, DC from 1990 to 2016. In 2016, Hawaii had the highest life
expectancy at birth (81.3 years) and Mississippi had the lowest (74.7 years), a 6.6-year
difference. Minnesota had the highest HALE at birth (70.3 years), and West Virginia had the
lowest (63.8 years), a 6.5-year difference. The leading causes of DALYs in the United States
for 1990 and 2016 were ischemic heart disease and lung cancer, while the third leading cause
in 1990 was low back pain, and the third leading cause in 2016 was chronic obstructive
pulmonary disease. Opioid use disorders moved from the 11th leading cause of DALYs in 1990
to the 7th leading cause in 2016, representing a 74.5% (95% UI, 42.8% to 93.9%) change.
In 2016, each of the following 6 risks individually accounted for more than 5% of
risk-attributable DALYs: tobacco consumption, high body mass index (BMI), poor diet, alcohol
and drug use, high fasting plasma glucose, and high blood pressure. Across all US states, the
top risk factors in terms of attributable DALYs were due to 1 of the 3 following causes: tobacco
consumption (32 states), high BMI (10 states), or alcohol and drug use (8 states).
CONCLUSIONS AND RELEVANCE There are wide differences in the burden of disease at the
state level. Specific diseases and risk factors, such as drug use disorders, high BMI, poor diet,
high fasting plasma glucose level, and alcohol use disorders are increasing and warrant
increased attention. These data can be used to inform national health priorities for research,
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P revious studies have reported on health disparitiesin US states and counties.1,2 These studies showedthat health disparities have increased with time.
Recent attention has focused on increased mortality in some
age groups and a decline in life expectancy.3 In addition,
the performance of the US health care system does not match
its level of spending on health and lags behind countries with
similar financial resources.4 For example, in 2014, US life
expectancy ranked 43rd in the world, although the United
States spent the most ($3.0 trillion) on health care, exceeding
the median amount spent by Organisation for Economic
Co-operation and Development countries by 35%.5
Several studies have shown large variations in risk factors
by state and county, and these variations have contributed to dif-
ferences in health outcomes.6-9 In the Global Burden of Disease
Study 2010 (GBD 2010) US Burden of Disease report, the follow-
ing risk factors were reported as the main causes associated with
US morbidity and mortality (percent contributed to total dis-
ability-adjusted life-years [DALYs] in 2010): poor diet (14%),
smoking (11%), high blood pressure (8%), and obesity (11%).10-12
None of the previous studies of US health have been as compre-
hensive as the GBD study.5,13-18 The GBD systematically ac-
counts for differences in data sources and biases and analyzes
levels and trends for causes and risk factors within the same com-
putational framework, which maximizes comparability across
states, years, and different age groups by sex. GBD is now con-
ducted on an annual cycle, with GBD 2016 providing updated
estimates of mortality, morbidity, and risk factors in 195 loca-
tions, including the United States, from 1990 to 2016.
The findings of GBD 2016 indicate that while the United
States overall is experiencing improvements in health out-
comes, the patterns of health burden at the state level vary
across geography. Routinely monitoring the trend of burden
of disease at the state level is essential given the vital role of
states in many aspects of health and social policy19—from the
Medicaid program to regulation of private insurers20 and con-
sidering that individual states also experience different eco-
nomic circumstances. The current study uses GBD 2016 to re-
port the change in burden of disease, including injuries and
risk factors at the state level, from 1990 to 2016.
Methods
Overview
The GBD study is estimated annually and each round of results
is internally consistent (cause-specific mortality estimates are
summed to match all-cause mortality estimates) and collec-
tively exhaustive (residual categories [“other”] are captured to
enable quantifying total burden) (Sections 1-5 in Supplement 1).
The numbers reported in the previous round of GBD are not iden-
tical to those of the current round (GBD 2016) for 2 main rea-
sons. First, since the GBD 2010 Special Communication regard-
ing US risk factors, there has been further refinement of the
“garbage coding” (ie, ill-defined causes of death) redistribution
methods (Supplement 1). Second, the new analysis at the state
level changes some of the estimation slightly when aggregated
to the national level. GBD 2016 provides a new time series.
The GBD 2016 methodology has been published pre-
viously.5,13-18 GBD uses several metrics to report results for health
loss related to specific diseases, injuries, and risk factors: deaths
and death rates, years of life lost (YLLs) due to premature mor-
tality, prevalence and prevalence rates for sequelae, years lived
with disability (YLDs), and DALYs (Box; Sections 2, 3, and 5 in
Supplement 1 and Appendix Table 2 in Supplement 2). GBD
provides a comprehensive assessment of all-cause mortality and
estimates for death due to 264 causes in 195 countries and ter-
ritories from 1990 to 2016, as well as 333 causes of DALYs (Appen-
dix Table 2 in Supplement 2). GBD 2016 has 4 levels of causes that
are mutually exclusive (Appendix Table 3 inSupplement 2). Level
1has3causes:communicable,maternal,neonatal,andnutritional
disorders; noncommunicable diseases; and injuries. Level 2 has
21 causes. Levels 3 and 4 consist of more disaggregated causes.
GBD 2016 documented each step of the estimation processes,
as well as data sources, in accordance with the Guidelines for Ac-
curate and Transparent Health Estimates Reporting.21 A more de-
tailedmethodologyisavailableintheappendixtothisarticle(Sec-
tions 8 and 9 in Supplement 1).
Data
To estimate the US burden of disease prevalence, computation
for each sequela began with a systematic analysis of published
studies and available data sources providing information on
prevalence, incidence, remission, and excess mortality, such as
the National Health and Nutrition Examination Surveys,22 state
inpatient databases,23 the National Ambulatory Medical Care
Survey,24 National Hospital Ambulatory Medical Care Survey,25
Medical Expenditure Panel Survey,26 National Comorbidity
Survey,27 National Epidemiological Survey on Alcohol and Re-
lated Conditions,28 National Survey on Drug Use and Health,29
US Department of Agriculture Continuing Survey of Food
Intakes,30 Marketscan,31 National Health Interview Survey,32 Be-
havioral Risk Factor Surveillance System,33 and the Centers for
Disease Control and Prevention Disease Surveillance Reports.34
Hospital inpatient data were extracted and used for this
analysis. Moreover, outpatient encounter data were available
for the United States through aggregate data derived from a
Key Points
Question How have the levels and trends of burden of diseases,
injuries, and risk factors in the United States changed from 1990 to
2016 by state?
Findings This study, involving examination of 333 causes and 84
risk factors, demonstrated that health in the United States
improved from 1990 to 2016, although the drivers of mortality and
morbidity have changed in some states, with specific risk factors
such as drug use disorders, high body mass index (BMI), and
alcohol use disorders being associated with adverse outcomes. In
5 states, the probability of death between ages 20 and 55 years
has increased more than 10% between 1990 and 2016.
Meaning Differences in health outcomes and drivers of morbidity
and mortality at the state level indicate the need for greater
investment in preventive and medical care across the life course.
The intersection of risk, mortality, and morbidity in particular
geographic areas needs to be further explored at the state level.
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database of claims information for US private and public in-
surance schemes for the years 2000, 2010, and 2012. GBD
methodology applied several correction factors to account for
bias in health service encounter data from these claims that
were available as aggregated by International Classification of
Diseases (ICD) code and by primary diagnosis only. First, for
chronic disorders, the study estimated the ratio between preva-
lence from primary diagnoses and prevalence from all diag-
noses associated with a claim. Second, the claims data were
used to generate the mean number of outpatient visits per dis-
order. Similarly, the study generated per-person discharge rates
from hospital inpatient data in the United States.
All-Cause Mortality and Cause of Death
All-causemortalitywasestimatedbyage,sex,geography,andyear
using 6 modeling approaches to assess cause-specific mortality;
the Cause of Death Ensemble Model was used to generate esti-
mates for the vast majority of causes. This analysis used deiden-
tified death records from the National Center for Health Statis-
tics(NCHS)35 andpopulationcountsfromtheUSCensusBureau,36
NCHS, and the Human Mortality Database.37 Deaths and popu-
lation were tabulated by county, age group, sex, year, and (in the
case of death data) cause. The cause list developed for the GBD13
is arranged hierarchically in 4 levels. Within each level, the cause
list is designed such that all deaths are assigned exactly 1 cause.
As part of the GBD study, a map has been developed that allows
ICD-9 and ICD-10 codes to be translated to GBD causes.
Previous studies have documented the existence of insuf-
ficiently specific or implausible causes of death used in death
registration data that may lead to misleading geographic and
temporal patterns.38 Algorithms developed for the GBD were
used to reallocate deaths assigned one of these garbage codes
to plausible alternatives.39 First, plausible target causes were
assigned to each garbage code or group of garbage codes. Sec-
ond, deaths were reassigned to specified target codes accord-
ing to proportions derived in 1 of 4 ways: (1) published litera-
ture or expert opinion; (2) regression models; (3) according to
the proportions initially observed among targets; and (4) for
HIV/AIDS specifically, by comparison to years before HIV/
AIDS became widespread. More detail on each of these meth-
ods is provided in Section 2 of Supplement 1.
Based on standard GBD methods, YLLs were computed by
multiplying the number of deaths from each cause in each age
group by the reference life expectancy at the mean of age of
death among those who died in the age group. The YLLs com-
putation is based on the precedent set by GBD and uses the
same life table standard for calculating YLLs in all locations and
years (essential for comparing estimates of YLLs across loca-
tions and years). The standard is meant to represent the mor-
tality experience of a population with minimal excess mortal-
ity using the lowest observed age-specific mortality rates in
2016 among all countries with a population greater than 5 mil-
lion. This standard does not vary with time because for most
populations, the number of YLLs (once normalized for popu-
lation size) is larger in earlier years than in later years due to
improving survival rather than an artifact of the standard used.
Analysis of Incidence, Prevalence, and YLDs
In this study, incidence and prevalence of diseases by age, sex,
cause, year, and geography were estimated using a wide range
of updated and standardized analytical procedures. GBD used
DisMod-MR, a Bayesian meta-regression tool, to determine
prevalence and incidence by cause and sequelae.40
Data sources used for quantifying nonfatal outcomes are
available online in the GBD results tool41 and in Section 3 of
Supplement 1. Prevalence of each sequela was multiplied by
the disability weight for the corresponding health state to cal-
culate YLDs for the sequela. The sum of all YLDs for relevant
sequelae equated to overall YLDs for each disease. Details on
disability weights for GBD 2016, including data collection and
disability weight construction, are described elsewhere.14
Analysis of DALYs and HALE
FollowingGBD2016methods,nationalandstate-levelDALYswere
computed by summing YLLs and YLDs for each cause, age, and
sex in 1990, 1995, 2000, 2005, 2010, and 2016 (Section 4 in
Supplement 1). DALYs were computed for 333 causes, with 95%
uncertainty intervals (UIs) capturing the uncertainty for both YLL
and YLD rates. HALE was calculated using the Sullivan method
and generated 95% UIs that indicated uncertainty for age-specific
death rates and YLDs per capita for each geography, age group,
sex, and year. HALE was calculated for the United States and for
each individual state using multiple-decrement life tables and es-
timated YLDs per capita; additional details on HALE methodol-
ogy are provided in Section 4 in Supplement 1.
Risk Factors
GBD 2016 used the comparative risk assessment framework to
estimate attributable deaths, DALYs, and trends in exposure by
age group, sex, year, and geography for risks from 1990 to 2016.
GBD has 84 behavioral, environmental and occupational, and
metabolic risks or clusters of risks (Section 5 in Supplement 1).
Risk-outcome pairs were included in the GBD 2016 study if they
Box. Glossary of Terms
Disability-adjusted life-years: a summary metric of population
health. DALYs represent a health gap and, as such, measure the state
of a population’s health compared to a normative goal. The goal is for
individuals to live the standard life expectancy in full health. DALYs
are the sum of 2 components: years of life lost (YLLs) and years lived
with disability (YLDs).
Healthy life expectancy: the number of years that a person at
a given age can expect to live in good health, taking into account
mortality and disability.
Summary Exposure Value: the relative risk–weighted prevalence of
exposure (developed for Global Burden of Diseases Study 2015).
Years lived with disability: computed as the prevalence of different
disease sequelae and injury sequelae multiplied by disability weights
for that sequela. Disability weights are selected on the basis of
surveys of the general population about the health loss associated
with the health state related to the disease sequela.
Years of life lost due to premature mortality: computed by
multiplying the number of deaths at each age by a standard life
expectancy at that age. The standard selected represents the
normative goal for survival and has been computed based on
the lowest recorded death rates across countries in 2010.
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met World Cancer Research Fund criteria for convincing or prob-
able evidence. Relative risk (RR) estimates were extracted from
published and unpublished randomized clinical trials, cohorts,
andpooledcohorts.Riskexposureswereestimatedbasedonpub-
lished studies, household surveys, US Census data, satellite data,
and other sources. Two modeling approaches, a Bayesian meta-
regression model and a spatiotemporal Gaussian process regres-
sion model, were developed for the GBD study and used to pool
data from different sources, adjust for bias in the data, and in-
corporate potential covariates. GBD used the counterfactual sce-
nario of theoretical minimum risk exposure level (ie, the level
for a given risk exposure that could minimize risk at the popu-
lation level) to attribute burden. A summary exposure value was
developed for GBD 2015 as the RR-weighted prevalence of expo-
sure (range, 0 [no excess risk exists in a population] to 1 [popu-




∑ Pri RRi – 1
RRmax – 1
Where Pri is prevalence of category i exposure; RRi is the RR of
the category i; and RRmax is the maximum RR observed (be-
tween categories). This quantity is estimated for each age group,
sex, geography, and year. In the case of dichotomous expo-
sure, summary exposure value is equal to prevalence. For con-





RR(x) P(x) dx – 1
RRmax – 1
Where (χ) is the density of exposure at level χ of exposure; (χ)
is the RR of the level χ; and RRmax is the highest RR that is sup-
ported by data and reflects a level in which more than 1% of
the population is exposed globally. In this study, summary ex-
posure value is reported on a scale from 0% to 100% to em-
phasize that it is risk-weighted prevalence.
To calculate risk-attributable fractions of disease burden
by cause, the effects of risk exposure levels were modeled, RRs
associated with risk exposure and specific health outcomes
were documented, and counterfactual levels of risk exposure
on estimates of national and state-level deaths, YLLs, YLDs,
and DALYs were computed. Detailed descriptions of the GBD
2016 methods for risk factor assessment and attribution are
published elsewhere (Section 5 in Supplement 1).5,13-18
Decomposition of Changes in Probability of Death
The probability of death was calculated for 3 summary age inter-
vals and the cause-specific contributions to each of these sum-
maryindicatorsforages0to20,20to55,and55to90years.These
age groups were chosen to reflect variations in trends and bur-
den for adolescents, young adults, and older people. For each
probability of death, the multiple decrement life-table method
wasusedtocomputetheprobabilityofdeathfromeachcauseand
the overall contribution of each cause of death to the summary
probability of death. Although discrete age categories from life
table calculations were used, the age categories slightly overlap
forcalculationsofprobabilityofdeath(ages20yearsand55years;
see Section 6 in Supplement 1). To decompose the key drivers of
life loss, the probability of death was determined and examined
in parallel to the cause fractions for that same age group. Addi-
tional information on the decomposition of changes in the prob-
ability of death, including the formulas used, is available in the
online methods section (Supplement 1).
Sociodemographic Index
GBD 2015 created a summary indicator that combines measures
of income per capita, educational attainment for age 15 years or
older, and total fertility rates.39,42-46 This indicator is updated for
each GBD round. The current sociodemographic index (SDI) was
used to compare observed patterns of health loss to expected pat-
terns for countries or locations with similar SDI scores. The SDI




2016]). In the United States in 2016, the SDI ranged from 0.874
in Mississippi to 0.978 in Washington, DC (global SDI values in
2016 ranged from 0.268 in Somalia to 0.978 in Washington, DC).
Results
US Mortality and YLLs
Table 1 lists the 25 leading causes of death and premature mor-
tality from 1990 to 2016. Ischemic heart disease (IHD); cancer of
the trachea, bronchus, and lung; chronic obstructive pulmonary
disease; Alzheimer disease and other dementias; and cancer of
the colon and rectum were the 5 leading causes of death. Despite
a 50.7% decline in age-standardized mortality and a 50.4% de-
cline in age-standardized YLLs, IHD remained the leading cause
of death and premature mortality. There was an increase in age-
standardized mortality and in age-standardized YLLs from 1990
for chronic obstructive pulmonary disease (13.8% for deaths and
4.6% for YLLs) and for Alzheimer disease and other dementias
(11.6% for deaths and 5.5% for YLLs). There was a decrease in age-
standardized mortality and in age-standardized YLLs for colon
and rectal cancer (29.6% for deaths and 27.9% for YLLs) and for
breast cancer (32.6% for deaths and 36.0% for YLLs). Deaths from
endocrine, metabolic, blood, and immune disorders increased
by 89.1%, and YLLs increased by 60.3% from 1990 to 2016 (an
increaseinrankfrom37in2010to22in2016).Othernotablefind-
ings seen in Table 1 are declines in deaths from self-harm by fire-
arm (13.2%) and physical violence by firearm (28.5%) but an in-
crease in self-harm by other means (16.9%).
US YLDs
Table 2 provides the 25 leading diseases and injuries contrib-
uting to YLDs. Low back pain and major depressive disorders
remained the first and second causes of YLDs in 2016. Age-
standardized rates of low back pain declined by 12.4%, while age-
standardized rates of major depressive disorder did not change
from 1990. Diabetes, which was the third leading cause of YLDs,
had a 29.6% increase in age-standardized rates from 1990, and
increased in rank from 8 in 1990 to 3 in 2016. From 1990 to 2016,
US Burden of Diseases, Injuries, and Disease Risk Factors, 1990-2016 Original Investigation Research
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falls had an increase of 22.2% in YLDs, opioid use disorders had
an increase of 10.9% in YLDs, and asthma had a decline of 12.4%
in age-standardized YLD rates. Other notable findings include
an increase of 9.7% in age-standardized YLD rates of hearing loss
due to aging and other causes.
US DALYs
Figure 1 shows the 25 leading causes of DALYs in 1990 and 2016
with their mean percentage change during the period. IHD and
lung cancer were the leading causes of DALYs in both years, but
the age-standardized rate declined between 1990 and 2016 by
49.7%forIHDandby32.5%forlungcancer.Theage-standardized
DALY rate for chronic obstructive pulmonary disease (the third
leading cause in 2016) increased by 5.5% between 1990 and 2016,
and for diabetes (the fourth leading cause in 2016), it increased
by 11%. Diabetes increased from the sixth leading cause in 1990
to the fourth in 2016, while low back pain declined from the third
leading cause to the fifth. Three leading causes of DALYS had de-
clines in age-standardized rates from 1990 to 2016: motor vehicle
road injuries (by 35.0%), breast cancer (by 34.3%), and colorec-
tal cancer (by 27.4%). Four leading causes of DALYS had increases
in age-standardized rates from 1990 to 2016: opioid use disor-
ders (by 47.9%), chronic kidney disease (by 44.3%), self-harm
by other means (by 20.3%), and falls (by 19.0%).
US Risk Factor Estimates
Figure 2 showsthenumberofdeathsandthepercentageofDALYs
from 17 risk factors in 2016. Diet, tobacco use, and high systolic
blood pressure were the leading causes of deaths while tobacco
use, high body mass index, and diet were the leading risk factors
for DALYs. For example, dietary risks accounted for 529 299
deaths in 2016, with 83.9% of these deaths due to cardiovascu-
lar diseases, and the remainder due to a combination of neo-
plasms and diabetes, and to urogenital, blood, and endocrine dis-
eases. Alcohol and drug use were the eighth leading cause of
death and the fourth leading cause of DALYs. In 2016, each of the
6 following risks accounted for more than 5% of DALYs: tobacco
consumption, high body mass index, diet, alcohol and drug use,
high fasting plasma glucose levels, and high blood pressure.
Attribution of DALYs to Risk Factors
In 2016, 44.9% of total DALYs in the United States were attrib-
utable to risk factors. Behavioral risk factors accounted for the
largest percentage of the attributable fraction of DALYs due to
all causes (43.5%), followed by metabolic (22.7%), and envi-
ronmental and occupational risks (3.7%) (Supplement 2).
Individual State Data
GBD 2016 showed substantial variations in the burden of dis-
eases, injuries, and risk factors by state. There was also a varia-
tion in trends by age, sex, and state (key findings and results
of burden by state in Supplement 3).
Life Expectancy and HALE
Life expectancy and HALE at birth for both sexes combined for
the United States, all 50 states, and for Washington, DC are shown
in Table 3. Hawaii had the highest life expectancy at birth in 2016
(81.3 years [95% UI, 80.6 to 81.9]), while Mississippi had the
lowest (74.7 years [95% UI, 73.5 to 76.1]; a 6.6-year difference).
Other states with high life expectancy were California (80.9 years
Table 2. US Years Lived With Disability (YLDs) Rank, Rate, and Percentage Change for the 25 Leading Causes of Disability and Injury, 1990 and 2016
Diseases and Injuries
YLD Rank No. of YLDs, in Thousands (95% Uncertainty Interval) % Change (95% Uncertainty Interval)
1990 2016 1990 2016 YLDs Age-Standardized YLD Rate
Low back pain 1 1 2461.1 (1732.3 to 3228.8) 3069.1 (2211.0 to 3989.6) 24.7 (10.9 to 39.6) −12.4 (−22.3 to −1.9)
Major depressive disorder 2 2 1726.2 (1192.3 to 2330.5) 2193.0 (1507.6 to 2990.5) 27.0 (21.6 to 32.7) 0.1 (−4.1 to 3.7)
Diabetes mellitus 8 3 1040.2 (716.1 to 1450.3) 2142.9 (1496.1 to 2932.8) 106.0 (92.9 to 119.0) 29.6 (21.2 to 37.5)
Other musculoskeletal disorders 4 4 1573.5 (1076.0 to 2193.9) 2076.5 (1423.2 to 2843.1) 32.0 (22.5 to 42.0) −2.3 (−8.7 to 4.3)
Migraine 3 5 1580.3 (1013.0 to 2205.4) 2010.1 (1296.4 to 2814.8) 27.2 (25.3 to 29.1) −1.4 (−2.8 to −0.1)
Neck pain 6 6 1281.8 (880.4 to 1788.4) 1982.6 (1381.1 to 2704.7) 54.7 (39.2 to 73.3) 2.9 (−7.5 to 15.0)
Anxiety disorders 5 7 1341.7 (940.7 to 1813.1) 1755.0 (1229.6 to 2383.4) 30.8 (25.7 to 36.0) 0.6 (−3.2 to 4.5)
Opioid use disorders 7 8 1256.2 (892.8 to 1588.8) 1638.9 (1144.0 to 2097.4) 30.5 (23.3 to 37.4) 10.9 (4.2 to 17.2)
Age-related and other hearing loss 9 9 886.9 (599.0 to 1269.5) 1528.0 (1035.7 to 2157.1) 72.3 (67.3 to 78.3) 9.7 (6.6 to 13.4)
Falls 11 10 722.7 (487.8 to 1010.2) 1389.1 (960.0 to 1922.6) 92.2 (83.8 to 102.6) 22.2 (17.7 to 27.8)
Chronic obstructive pulmonary disease 12 11 674.4 (585.1 to 743.9) 1184.6 (1035.1 to 1307.3) 75.7 (66.8 to 84.9) 7.4 (2.0 to 12.9)
Osteoarthritis 14 12 573.5 (377.6 to 829.6) 1005.0 (659.5 to 1448.2) 75.2 (68.5 to 82.6) 7.9 (3.7 to 12.5)
Acne vulgaris 10 13 855.9 (573.6 to 1236.1) 992.6 (668.0 to 1441.4) 16.0 (14.3 to 17.8) −1.5 (−3.0 to 0.2)
Dermatitis 13 14 659.8 (405.3 to 1032.9) 830.2 (515.1 to 1296.5) 25.8 (24.0 to 28.0) 1.2 (0.3 to 2.2)
Ischemic stroke 18 15 464.0 (321.3 to 607.7) 716.9 (500.9 to 912.7) 54.5 (41.5 to 64.9) −3.5 (−11.2 to 2.9)
Schizophrenia 17 16 503.3 (365.0 to 627.7) 685.2 (506.9 to 847.9) 36.1 (32.7 to 39.5) 1.7 (−0.0 to 3.5)
Edentulism and severe tooth loss 19 17 458.0 (301.1 to 649.2) 662.2 (432.6 to 936.6) 44.6 (42.9 to 46.3) −8.6 (−9.6 to −7.4)
Alcohol use disorders 15 18 558.2 (380.7 to 771.4) 633.9 (440.3 to 852.1) 13.6 (5.0 to 23.7) −8.6 (−15.2 to −1.1)
Alzheimer disease and other dementias 23 19 360.8 (253.3 to 476.0) 597.6 (431.4 to 774.4) 65.6 (54.5 to 78.4) −1.1 (−7.0 to 5.7)
Rheumatoid arthritis 25 20 350.2 (245.4 to 464.0) 592.4 (412.6 to 775.9) 69.1 (63.1 to 75.5) 10.1 (6.4 to 14.1)
Asthma 16 21 522.1 (342.5 to 744.9) 591.0 (393.8 to 832.4) 13.2 (7.5 to 19.2) −12.4 (−17.1 to −7.6)
Other mental and substance use
disorders
20 22 421.2 (288.4 to 601.1) 566.1 (390.0 to 804.1) 34.4 (32.9 to 35.9) 0.5 (−0.5 to 1.6)
Dysthymia 22 23 375.1 (254.3 to 548.2) 522.0 (352.7 to 753.3) 39.2 (31.7 to 47.2) 2.5 (−2.7 to 8.1)
Bipolar disorder 21 24 376.4 (236.7 to 545.7) 489.1 (309.6 to 703.2) 29.9 (27.9 to 32.1) −0.4 (−1.9 to 1.0)
Psoriasis 24 25 351.9 (253.0 to 459.4) 488.2 (350.9 to 635.5) 38.7 (36.9 to 40.6) 1.9 (0.6 to 3.2)
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[95% UI, 79.9 to 81.9]), Connecticut (80.8 years [95% UI, 79.7 to
81.8]), Minnesota (80.8 years [95% UI, 80.0 to 81.6]), New York
(80.5 years [95% UI, 79.4 to 81.6]), Massachusetts (80.4 years
[95% UI, 79.6 to 81.1]), Colorado (80.2 years [95% UI, 79.4 to
80.9]), New Jersey (80.2 years [95% UI, 79.3 to 80.9]), and Wash-
ington (80.2 years [95% UI, 79.5 to 80.8]). Other states with low
life expectancy were West Virigina (75.3 years [95% UI, 74.4 to
76.0]),Alabama(75.4years[95%UI,74.1to76.7]),Louisiana(75.6
years [95% UI, 74.9 to 76.4]), Oklahoma (75.7 years [95% UI, 75.0
to 76.4]), Arkansas (75.8 years [95% UI, 74.9 to 76.8]), and Ken-
tucky (75.8 years [95% UI, 74.9 to 76.6]). In 2016, Minnesota had
thehighestHALEatbirthwith70.3years,whileWestVirginiahad
the lowest at 63.8 years, a 6.5-year difference. Only 2 states,
Minnesota and Hawaii, had HALE values greater than 70.0 years
at birth in 2016. In terms of life expectancy in 2016, only 9 states
had life expectancy values greater than 80.0 years.
Male life expectancy and HALE at birth for the United States
overall, for all states, and for Washington, DC, are shown in
Table 4. Minnesota had the highest life expectancy in 2016 (78.7
years [95% UI, 77.5 to 79.8]) and HALE (69.1 years [95% UI, 66.3
to 71.9]), followed by California (life expectancy, 78.6 years [95%
UI, 77.2 to 80.1]; and HALE, 68.6 years [95% UI, 65.5 to 71.6]).
Mississippi had the lowest life expectancy for males in 2016 (71.8
years [95% UI, 70.1 to 73.8]) and ranked 49th for HALE (63.0
years [95% UI, 60.3 to 65.6]), while West Virginia had the low-
est HALE (62.2 years [95% UI, 54.9 to 65.0]) and ranked 49th
for life expectancy (72.7 years [95% UI, 71.5 to 73.9).
Female life expectancy and HALE at birth for the United
States,forallstates,andforWashington,DC,areshowninTable5.
Hawaii had the highest life expectancy in 2016 (84.1 years [95%
UI, 83.2 to 85.0) and HALE (71.9 years [95% UI, 68.3 to 75.1), fol-
lowed by life expectancy for California (83.1 years [95% UI, 81.8
to 84.3]) and life expectancy for Connecticut (83.1 years [95% UI,
81.7 to 84.4]); the second highest HALE was for Minnesota (71.4
years [95% UI, 68.3 to 74.5]). Mississippi had the lowest life ex-
pectancyforfemales(77.7years[95%UI,76.1to79.6]),whileWest
Virginia had the lowest HALE (65.5 years [95% UI, 61.9 to 68.5]).
Table 6 presents the age-standardized death rates, age-
standardized YLL rates, and age-standardized YLD rates in 1990
and 2016 and their ranks by state. The 3 measurements varied
widely between the states in 2016, ranging from 767.6 deaths per
100 000 in Mississippi to 465.8 deaths per 100 000 in Hawaii,
from 17 775.9 YLLs per 100 000 in Mississippi to 9901.8 YLLs per
100 000 in Minnesota, and from 13 090.6 YLDs per 100 000 in
West Virginia to 10 582.8 YLDs per 100 000 in Minnesota. A no-
table improvement was observed in Washington, DC (decreases
from1042.7deathsper100 000to603.3deathsper100 000,from
29 536.9YLLSper100 000to13 635.9YLLsper100 000,andfrom
12 230.8 YLDs per 100 000 to 11 421.1 YLDs per 100 000) and in
California (decreases from 719.1 deaths per 100 000 to 491.7
Figure 1. Top 25 Causes of Disability-Adjusted Life-Years (DALYs) and % Change in Number of DALYs, All-Age DALYs, and Age-Standardized DALYs, 1990-2016
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deaths per 100 000, from 15 903.4 YLLS per 100 000 to 9987.0
YLLsper100 000,andfrom11 170.5YLDsper100 000to10 990.4
YLDs per 100 000). Decreases in mortality and increases in mor-
bidityweremoreapparentinOhio(from761.5deathsper100 000
to 644.1 deaths per 100 000, from 16 349.6 YLLs per 100 000 to
13 853.3 YLLs per 100 000, and from 12 009.0 YLDs per 100 000
to12 334.7YLDsper100 000)andinOklahoma(from773.8deaths
per 100 000 to 725.3 deaths per 100 000, from 17 062.7 YLLs per
100 000 to 16 379.3 YLLs per 100 000, and from 12 036.5 YLDs
per100 000to12 549.7YLDsper100 000).Theage-standardized
death rates and age-standardized YLL rates declined in all states,
but the level of decline for deaths ranged from 6.3% in Oklahoma
to 42.1% in Washington, DC and the level of decline for YLLs
ranged from 4.0% for Oklahoma to 53.8% for Washington, DC.
Age-standardized YLD rates increased by 4.4% for West Virginia
and declined by 6.6% for Washington, DC.
Decomposition of the Probability of Death by Age and State
The decomposition of change in the probability of death from
birth to age 20 years, ages 20 to 55 years, and ages 55 to 90 years
areshowninFigure3,Figure4,andFigure5.FortheUnitedStates
and each state, these figures show the change in the probability
of death from 1990 to 2016. In addition, these figures show
changes in the probability of death over the interval due to
changes in causes of death (GBD cause hierarchy level 2). The
change in the probability of death from birth to age 20 years
Figure 2. Number of Deaths and Percentage of Disability-Adjusted Life-Years Related to the 17 Leading Risk Factors in the United States, 2016
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Table 3. Life Expectancy and Healthy Life Expectancy at Birth for the United States, the 50 States, and Washington, DC, 1990 and 2016, Both Sexes
Location
Life Expectancy at Birth, y Healthy Life Expectancy at Birth, y
1990 2016 1990 2016
Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank
United States 75.5 (75.4-75.5) 78.9 (78.7-79.0) 65.3 (62.4-67.9) 67.7 (64.5-70.5) .
Alabama 73.7 (73.3-74.2) 47 75.4 (74.1-76.7) 49 63.7 (61.0-66.3) 48 64.6 (61.5-67.6) 48
Alaska 75.0 (74.5-75.6) 34 78.1 (76.9-79.4) 34 65.0 (62.2-67.6) 32 67.3 (64.2-70.3) 33
Arizona 76.1 (75.7-76.6) 22 79.5 (78.6-80.4) 19 65.4 (62.4-68.1) 24 67.7 (64.3-70.8) 27
Arkansas 74.4 (74.0-74.8) 43 75.8 (74.9-76.8) 45 64.5 (61.7-67.1) 40 65.5 (62.6-68.2) 44
California 75.9 (75.5-76.4) 24 80.9 (79.9-81.9) 2 66.1 (63.3-68.6) 19 69.9 (66.6-72.8) 3
Colorado 77.1 (76.7-77.4) 6 80.2 (79.4-80.9) 7 66.7 (63.7-69.4) 10 68.9 (65.7-71.8) 9
Connecticut 77.0 (76.6-77.5) 7 80.8 (79.7-81.8) 3 66.5 (63.5-69.1) 12 69.0 (65.7-72.1) 6
Delaware 74.9 (74.5-75.3) 37 78.6 (77.9-79.4) 28 64.6 (61.7-67.2) 39 67.2 (64.0-70.1) 34
Florida 76.0 (75.6-76.4) 23 79.6 (78.6-80.5) 15 65.5 (62.6-68.2) 23 67.9 (64.5-71.0) 24
Georgia 73.8 (73.2-74.3) 46 77.4 (76.2-78.4) 41 63.9 (61.0-66.5) 44 66.6 (63.5-69.5) 38
Hawaii 78.5 (78.2-78.9) 1 81.3 (80.6-81.9) 1 68.2 (65.2-70.9) 1 70.1 (66.9-73.0) 2
Idaho 77.0 (76.6-77.5) 8 79.1 (78.1-80.3) 23 66.4 (63.5-69.0) 13 67.9 (64.5-70.9) 25
Illinois 75.0 (74.7-75.4) 35 79.1 (78.4-79.8) 24 65.2 (62.5-67.7) 29 68.3 (65.3-71.0) 18
Indiana 75.4 (75.0-75.9) 27 77.2 (76.0-78.5) 42 65.1 (62.2-67.7) 31 66.0 (62.9-69.0) 42
Iowa 77.3 (77.0-77.7) 5 79.5 (78.6-80.4) 17 67.4 (64.6-70.0) 4 68.9 (65.8-71.7) 7
Kansas 76.8 (76.4-77.3) 12 78.5 (77.3-79.7) 30 66.8 (64.0-69.3) 8 67.8 (64.8-70.7) 26
Kentucky 74.4 (74.1-74.8) 42 75.8 (74.9-76.6) 46 63.7 (60.8-66.5) 45 64.3 (61.2-67.3) 50
Louisiana 73.3 (73.0-73.7) 49 75.6 (74.9-76.4) 48 63.2 (60.4-65.8) 50 65.0 (62.0-67.7) 46
Maine 76.3 (75.9-76.7) 21 79.0 (78.3-79.7) 26 66.1 (63.3-68.6) 17 68.0 (65.0-70.9) 21
Maryland 74.8 (74.5-75.2) 38 79.2 (78.5-79.9) 21 64.7 (61.8-67.3) 37 68.0 (65.0-70.7) 22
Massachusetts 76.7 (76.3-77.1) 15 80.4 (79.6-81.1) 6 66.1 (63.2-68.7) 18 68.9 (65.6-71.8) 8
Michigan 75.2 (74.9-75.5) 33 78.0 (77.3-78.7) 35 64.9 (62.0-67.6) 35 67.0 (63.9-69.9) 35
Minnesota 77.8 (77.4-78.2) 3 80.8 (80.0-81.6) 4 67.9 (65.1-70.4) 2 70.3 (67.4-73.0) 1
Mississippi 73.1 (72.6-73.6) 50 74.7 (73.5-76.1) 51 63.7 (61.0-66.1) 46 64.9 (62.1-67.6) 47
Missouri 75.3 (75.0-75.7) 31 77.4 (76.8-78.2) 40 65.3 (62.4-67.9) 28 66.5 (63.4-69.2) 39
Montana 76.4 (75.9-76.9) 18 78.9 (77.7-80.1) 27 66.0 (63.1-68.6) 20 67.7 (64.5-70.9) 28
Nebraska 76.9 (76.5-77.3) 10 79.4 (78.8-80.1) 20 67.0 (64.2-69.5) 7 68.8 (65.7-71.5) 12
Nevada 74.5 (74.1-74.9) 41 78.1 (77.3-79.0) 33 64.3 (61.5-67.0) 41 66.9 (63.9-69.7) 36
New Hampshire 76.7 (76.4-77.1) 14 79.9 (79.2-80.6) 11 66.2 (63.3-68.8) 16 68.5 (65.3-71.4) 14
New Jersey 75.4 (75.1-75.8) 26 80.2 (79.3-80.9) 8 65.3 (62.5-67.9) 25 68.8 (65.7-71.8) 10
New Mexico 75.9 (75.4-76.4) 25 77.8 (76.5-79.1) 38 65.3 (62.4-68.0) 26 66.3 (63.0-69.4) 40
New York 74.7 (74.3-75.2) 39 80.5 (79.4-81.6) 5 64.3 (61.4-67.0) 42 68.5 (65.1-71.6) 15
North Carolina 74.7 (74.4-75.1) 40 77.9 (77.3-78.6) 37 64.9 (62.2-67.5) 34 67.4 (64.4-70.1) 32
North Dakota 77.7 (77.2-78.2) 4 79.8 (78.8-80.9) 12 67.6 (64.7-70.1) 3 68.8 (65.6-71.8) 11
Ohio 75.4 (75.0-75.7) 29 77.5 (76.8-78.2) 39 64.9 (62.0-67.6) 33 66.1 (62.9-69.0) 41
Oklahoma 75.0 (74.6-75.4) 36 75.7 (75.0-76.4) 47 64.6 (61.7-67.2) 38 64.5 (61.4-67.4) 49
Oregon 76.3 (76.0-76.7) 19 79.5 (78.9-80.2) 16 66.0 (63.1-68.5) 21 68.4 (65.3-71.2) 17
Pennsylvania 75.4 (75.1-75.7) 28 78.5 (77.9-79.2) 29 64.7 (61.8-67.5) 36 66.8 (63.7-69.8) 37
Rhode Island 76.6 (76.1-77.0) 17 79.6 (78.6-80.7) 13 65.8 (62.8-68.5) 22 68.1 (64.9-71.2) 20
South Carolina 73.7 (73.2-74.2) 48 76.8 (75.7-77.8) 43 63.6 (60.8-66.2) 49 65.8 (62.7-68.7) 43
South Dakota 76.9 (76.4-77.4) 11 79.1 (78.1-80.1) 25 67.1 (64.3-69.6) 6 68.4 (65.3-71.4) 16
Tennessee 74.3 (74.0-74.7) 44 76.1 (75.5-77.0) 44 64.2 (61.4-66.8) 43 65.4 (62.3-68.2) 45
Texas 75.3 (74.8-75.6) 32 78.5 (77.8-79.3) 31 65.3 (62.5-67.9) 27 67.4 (64.4-70.3) 29
Utah 77.9 (77.6-78.3) 2 79.6 (79.0-80.3) 14 67.1 (64.1-69.8) 5 68.2 (64.9-71.1) 19
Vermont 76.6 (76.2-77.0) 16 79.9 (79.2-80.7) 10 66.4 (63.5-69.0) 14 69.0 (65.9-71.8) 5
Virginia 75.3 (75.0-75.7) 30 79.2 (78.5-79.9) 22 65.2 (62.3-67.8) 30 68.0 (64.9-70.8) 23
Washington 76.8 (76.5-77.2) 13 80.2 (79.5-80.8) 9 66.5 (63.7-69.1) 11 69.1 (65.8-71.9) 4
West Virginia 74.3 (74.0-74.7) 45 75.3 (74.4-76.0) 50 63.7 (60.7-66.3) 47 63.8 (60.7-66.7) 51
Wisconsin 76.9 (76.6-77.3) 9 79.5 (78.8-80.1) 18 66.8 (63.9-69.3) 9 68.6 (65.4-71.5) 13
Wyoming 76.3 (75.8-76.8) 20 78.4 (77.2-79.5) 32 66.2 (63.3-68.8) 15 67.4 (64.1-70.4) 30
Washington, DC 68.4 (67.7-69.0) 51 78.0 (76.8-79.1) 36 59.1 (56.6-61.6) 51 67.4 (64.4-70.3) 31
Abbreviation: UI, uncertainty interval.
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Table 4. Life Expectancy and Healthy Life Expectancy at Birth for the United States, the 50 States, and Washington, DC, 1990 and 2016, Males
Location
Life Expectancy at Birth, y Healthy Life Expectancy at Birth, y
1990 2016 1990 2016
Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank
United States 71.9 (71.8-72.1) 76.5 (76.2-76.7) 63.0 (60.5-65.2) 66.3 (63.5-68.8)
Alabama 69.7 (69.1-70.4) 48 72.6 (70.8-74.5) 50 61.1 (58.6-63.4) 47 63.0 (60.1-65.8) 48
Alaska 71.9 (71.0-72.6) 31 75.9 (74.2-77.7) 33 63.0 (60.5-65.4) 29 66.2 (63.3-69.2) 31
Arizona 72.7 (72.1-73.3) 22 77.1 (75.9-78.5) 20 63.2 (60.6-65.6) 23 66.5 (63.3-69.4) 27
Arkansas 70.6 (70.0-71.2) 44 73.3 (71.8-74.7) 45 62.0 (59.6-64.4) 41 64.1 (61.5-66.5) 44
California 72.6 (72.0-73.3) 23 78.6 (77.2-80.1) 2 63.9 (61.5-66.2) 20 68.6 (65.5-71.6) 2
Colorado 73.9 (73.4-74.5) 6 78.1 (77.0-79.1) 6 64.9 (62.3-67.3) 6 67.8 (65.0-70.6) 5
Connecticut 73.7 (73.1-74.4) 10 78.4 (76.7-79.9) 4 64.3 (61.6-66.7) 15 67.6 (64.5-70.6) 8
Delaware 71.7 (71.2-72.3) 33 76.2 (75.1-77.4) 29 62.6 (60.0-64.9) 35 65.8 (63.0-68.5) 33
Florida 72.3 (71.7-72.9) 25 77.0 (75.4-78.3) 22 63.1 (60.6-65.4) 27 66.4 (63.3-69.4) 28
Georgia 69.8 (69.1-70.6) 46 74.8 (73.1-76.3) 42 61.3 (58.8-63.5) 45 65.2 (62.2-68.0) 38
Hawaii 75.5 (75.0-76.1) 1 78.4 (77.4-79.4) 3 66.3 (63.7-68.8) 1 68.3 (65.3-71.1) 3
Idaho 74.0 (73.3-74.7) 5 77.2 (75.6-78.8) 16 64.6 (62.0-67.0) 12 67.0 (63.8-70.0) 19
Illinois 71.5 (70.9-72.0) 37 76.6 (75.5-77.6) 26 62.9 (60.5-65.1) 31 66.8 (64.0-69.4) 21
Indiana 72.0 (71.4-72.7) 28 74.8 (73.1-76.5) 41 63.1 (60.5-65.4) 28 64.8 (61.9-67.7) 40
Iowa 73.9 (73.3-74.5) 7 77.2 (76.0-78.3) 18 65.2 (62.7-67.5) 5 67.6 (64.8-70.1) 7
Kansas 73.5 (72.8-74.1) 13 76.1 (74.4-77.9) 31 64.7 (62.3-67.0) 10 66.5 (63.7-69.5) 25
Kentucky 70.8 (70.3-71.3) 42 73.2 (72.0-74.4) 47 61.3 (58.7-63.8) 44 62.8 (59.9-65.7) 50
Louisiana 69.4 (68.8-69.9) 49 72.9 (71.8-74.0) 48 60.7 (58.3-62.9) 50 63.3 (60.7-65.8) 47
Maine 72.9 (72.4-73.5) 21 76.5 (75.4-77.5) 27 64.0 (61.5-66.2) 18 66.5 (63.6-69.2) 26
Maryland 71.4 (70.9-71.9) 38 76.8 (75.8-77.7) 24 62.5 (60.1-64.8) 37 66.7 (63.9-69.4) 22
Massachusetts 73.3 (72.8-73.9) 14 77.9 (76.9-78.9) 9 63.9 (61.3-66.4) 21 67.4 (64.3-70.1) 12
Michigan 71.9 (71.4-72.3) 32 75.6 (74.7-76.7) 35 62.8 (60.3-65.1) 34 65.6 (62.8-68.4) 35
Minnesota 74.5 (74.0-75.0) 3 78.7 (77.5-79.8) 1 65.9 (63.5-68.1) 2 69.1 (66.3-71.9) 1
Mississippi 69.0 (68.3-69.7) 50 71.8 (70.1-73.8) 51 60.9 (58.6-63.0) 49 63.0 (60.3-65.6) 49
Missouri 71.6 (71.0-72.1) 34 74.9 (73.9-76.0) 40 62.9 (60.5-65.2) 30 65.1 (62.2-67.6) 39
Montana 73.2 (72.5-73.9) 18 76.8 (75.1-78.7) 23 64.1 (61.4-66.3) 17 66.6 (63.5-69.8) 23
Nebraska 73.6 (73.0-74.0) 12 77.2 (76.1-78.1) 19 64.9 (62.5-67.1) 7 67.5 (64.7-70.1) 9
Nevada 71.3 (70.7-71.8) 39 75.9 (74.6-77.1) 34 62.3 (59.8-64.6) 40 65.7 (62.9-68.4) 34
New Hampshire 73.6 (73.1-74.2) 11 77.7 (76.6-78.7) 11 64.2 (61.6-66.5) 16 67.1 (64.3-70.0) 17
New Jersey 72.2 (71.6-72.7) 26 77.8 (76.6-78.9) 10 63.1 (60.6-65.5) 24 67.3 (64.4-70.1) 14
New Mexico 72.4 (71.7-73.2) 24 75.0 (73.1-76.9) 39 63.1 (60.5-65.6) 25 64.7 (61.4-67.9) 42
New York 70.9 (70.3-71.6) 40 78.1 (76.6-79.7) 5 61.7 (59.2-64.1) 42 67.1 (64.0-70.1) 16
North Carolina 70.9 (70.4-71.3) 41 75.4 (74.4-76.4) 36 62.3 (59.9-64.5) 39 65.9 (63.2-68.4) 32
North Dakota 74.2 (73.6-74.9) 4 77.2 (75.7-78.8) 15 65.5 (63.0-67.7) 3 67.4 (64.3-70.2) 13
Ohio 72.1 (71.7-72.6) 27 75.1 (74.0-76.1) 37 62.9 (60.3-65.1) 33 64.8 (61.8-67.4) 41
Oklahoma 71.6 (71.0-72.1) 35 73.2 (72.1-74.4) 46 62.5 (60.0-64.8) 36 63.3 (60.5-66.1) 46
Oregon 73.2 (72.7-73.7) 17 77.4 (76.5-78.3) 13 63.9 (61.3-66.3) 19 67.2 (64.5-69.9) 15
Pennsylvania 71.9 (71.5-72.4) 29 76.0 (74.9-77.0) 32 62.4 (59.8-64.8) 38 65.3 (62.5-68.0) 37
Rhode Island 73.1 (72.5-73.7) 19 77.2 (75.6-78.5) 17 63.6 (61.0-66.1) 22 66.6 (63.7-69.6) 24
South Carolina 69.8 (69.0-70.5) 47 74.2 (72.5-75.9) 43 61.0 (58.5-63.3) 48 64.3 (61.4-67.1) 43
South Dakota 73.2 (72.6-73.9) 16 76.7 (75.1-78.2) 25 64.7 (62.2-66.9) 11 67.1 (64.2-70.0) 18
Tennessee 70.5 (70.0-71.0) 45 73.5 (72.5-74.7) 44 61.6 (59.2-63.9) 43 63.8 (61.0-66.4) 45
Texas 71.5 (70.9-72.1) 36 76.1 (75.0-77.3) 30 62.9 (60.4-65.2) 32 66.2 (63.5-69.0) 30
Utah 75.0 (74.5-75.5) 2 77.9 (77.0-78.9) 8 65.5 (62.8-67.9) 4 67.5 (64.7-70.2) 10
Vermont 73.3 (72.8-73.9) 15 77.6 (76.4-78.7) 12 64.3 (61.7-66.6) 14 67.7 (64.8-70.3) 6
Virginia 71.9 (71.4-72.3) 30 77.0 (76.0-78.0) 21 63.1 (60.6-65.4) 26 67.0 (64.1-69.6) 20
Washington 73.8 (73.3-74.3) 8 78.1 (77.1-79.1) 7 64.8 (62.2-67.0) 9 68.1 (65.1-70.8) 4
West Virginia 70.6 (70.1-71.2) 43 72.7 (71.5-73.9) 49 61.2 (58.6-63.5) 46 62.2 (59.4-65.0) 51
Wisconsin 73.7 (73.2-74.2) 9 77.3 (76.2-78.2) 14 64.8 (62.3-67.1) 8 67.4 (64.6-70.1) 11
Wyoming 73.1 (72.4-73.8) 20 76.2 (74.6-77.8) 28 64.3 (61.7-66.7) 13 66.3 (63.2-69.3) 29
Washington, DC 62.3 (61.4-63.3) 51 75.1 (73.4-76.6) 38 54.5 (52.3-56.8) 51 65.5 (62.6-68.3) 36
Abbreviation: UI, uncertainty interval.
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Table 5. Life Expectancy and Healthy Life Expectancy at Birth for the United States, the 50 States, and Washington, DC, 1990 and 2016, Females
Location
Life Expectancy at Birth, y Healthy Life Expectancy at Birth, y
1990 2016 1990 2016
Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank Estimate (95% UI) Rank
United States 78.9 (78.8-79.0) 81.2 (81.0-81.5) 67.5 (64.2-70.4) 69.0 (65.5-72.1)
Alabama 77.6 (77.0-78.3) 46 78.1 (76.6-79.7) 49 66.2 (63.0-69.1) 46 66.2 (62.7-69.5) 48
Alaska 78.8 (78.0-79.5) 28 80.5 (78.9-82.1) 36 67.4 (64.2-70.3) 31 68.5 (65.0-72.0) 34
Arizona 79.7 (79.1-80.2) 19 81.9 (80.7-83.0) 15 67.7 (64.4-70.8) 25 69.0 (65.2-72.4) 25
Arkansas 78.2 (77.6-78.8) 39 78.5 (77.3-79.8) 45 66.9 (63.8-69.8) 34 67.1 (63.7-70.1) 44
California 79.2 (78.7-79.9) 25 83.1 (81.8-84.3) 2 68.2 (65.1-71.0) 16 71.1 (67.7-74.3) 3
Colorado 80.0 (79.6-80.5) 11 82.3 (81.3-83.2) 9 68.4 (65.1-71.5) 11 69.9 (66.3-73.1) 13
Connecticut 80.1 (79.5-80.7) 9 83.1 (81.7-84.4) 3 68.4 (65.2-71.4) 12 70.4 (66.8-73.9) 4
Delaware 77.9 (77.4-78.4) 45 81.0 (80.0-82.0) 29 66.4 (63.2-69.4) 44 68.6 (65.2-71.8) 32
Florida 79.7 (79.2-80.2) 16 82.2 (81.1-83.4) 11 67.9 (64.6-71.0) 22 69.4 (65.8-72.8) 21
Georgia 77.5 (77.0-78.2) 47 79.8 (78.2-81.4) 41 66.4 (63.2-69.3) 45 68.1 (64.6-71.1) 38
Hawaii 81.8 (81.3-82.3) 1 84.1 (83.2-85.0) 1 70.2 (67.0-73.1) 1 71.9 (68.3-75.1) 1
Idaho 80.1 (79.5-80.8) 8 81.2 (79.8-82.5) 26 68.3 (65.0-71.4) 13 68.8 (65.2-72.1) 28
Illinois 78.4 (77.9-78.8) 36 81.5 (80.6-82.3) 23 67.5 (64.4-70.3) 28 69.8 (66.4-72.7) 16
Indiana 78.7 (78.1-79.3) 31 79.6 (77.9-81.2) 42 67.1 (63.8-70.1) 33 67.3 (63.8-70.6) 43
Iowa 80.6 (80.1-81.1) 6 81.9 (80.8-83.1) 16 69.5 (66.4-72.4) 5 70.2 (66.8-73.4) 9
Kansas 80.1 (79.5-80.7) 10 80.9 (79.1-82.5) 30 68.7 (65.5-71.7) 7 69.1 (65.7-72.4) 23
Kentucky 78.1 (77.5-78.6) 42 78.4 (77.3-79.4) 46 66.1 (62.8-69.1) 48 65.8 (62.2-69.1) 50
Louisiana 77.1 (76.6-77.7) 50 78.4 (77.4-79.4) 47 65.7 (62.5-68.7) 50 66.6 (63.2-69.8) 47
Maine 79.5 (79.0-80.0) 22 81.5 (80.7-82.4) 22 68.2 (65.0-71.1) 15 69.6 (66.3-72.8) 18
Maryland 78.1 (77.7-78.6) 40 81.5 (80.6-82.4) 21 66.7 (63.5-69.7) 38 69.2 (65.8-72.4) 22
Massachusetts 79.8 (79.2-80.2) 15 82.7 (81.8-83.6) 6 68.0 (64.8-71.0) 19 70.3 (66.8-73.7) 5
Michigan 78.4 (78.0-78.8) 34 80.4 (79.5-81.4) 37 66.9 (63.7-69.9) 35 68.3 (64.9-71.4) 36
Minnesota 80.9 (80.5-81.4) 3 82.9 (81.8-83.9) 4 69.9 (66.7-72.7) 2 71.4 (68.3-74.5) 2
Mississippi 77.2 (76.6-77.8) 49 77.7 (76.1-79.6) 51 66.5 (63.5-69.2) 43 66.8 (63.7-70.0) 46
Missouri 79.0 (78.5-79.4) 27 79.9 (79.0-80.9) 39 67.6 (64.3-70.5) 26 67.9 (64.5-71.0) 40
Montana 79.7 (79.0-80.4) 17 81.0 (79.4-82.5) 28 68.1 (64.9-71.1) 18 68.8 (65.2-72.2) 29
Nebraska 80.1 (79.6-80.6) 7 81.8 (80.8-82.7) 17 68.9 (65.7-71.9) 6 70.0 (66.6-73.0) 11
Nevada 78.0 (77.5-78.5) 43 80.5 (79.5-81.7) 35 66.6 (63.4-69.5) 41 68.2 (64.7-71.4) 37
New Hampshire 79.7 (79.2-80.1) 18 82.2 (81.4-83.0) 13 68.0 (64.7-71.0) 20 69.9 (66.2-73.0) 12
New Jersey 78.5 (78.1-79.0) 32 82.4 (81.4-83.5) 8 67.4 (64.2-70.3) 30 70.2 (66.8-73.4) 8
New Mexico 79.4 (78.8-80.1) 24 80.7 (79.1-82.3) 33 67.5 (64.2-70.6) 27 67.9 (64.3-71.5) 39
New York 78.3 (77.8-78.9) 38 82.7 (81.3-84.2) 5 66.7 (63.4-69.8) 39 69.7 (65.9-73.3) 17
North Carolina 78.4 (77.9-78.8) 35 80.3 (79.5-81.2) 38 67.4 (64.3-70.2) 29 68.8 (65.4-71.7) 30
North Dakota 81.3 (80.6-82.0) 2 82.6 (81.3-83.9) 7 69.8 (66.5-72.7) 3 70.3 (66.8-73.6) 7
Ohio 78.5 (78.1-79.0) 33 79.9 (79.1-80.7) 40 66.8 (63.5-69.9) 37 67.4 (63.9-70.5) 41
Oklahoma 78.3 (77.9-78.8) 37 78.2 (77.2-79.2) 48 66.6 (63.3-69.6) 42 65.8 (62.3-68.9) 49
Oregon 79.4 (79.0-79.9) 23 81.7 (80.8-82.6) 19 68.0 (64.8-70.9) 21 69.5 (66.3-72.7) 19
Pennsylvania 78.7 (78.3-79.1) 29 81.0 (80.2-81.9) 27 66.9 (63.6-70.0) 36 68.4 (64.7-71.6) 35
Rhode Island 79.7 (79.1-80.3) 20 82.0 (80.7-83.3) 14 67.8 (64.5-70.8) 23 69.4 (65.8-72.9) 20
South Carolina 77.4 (76.8-78.1) 48 79.4 (77.7-80.9) 43 66.1 (62.9-69.0) 49 67.3 (63.7-70.6) 42
South Dakota 80.6 (80.0-81.2) 5 81.6 (80.1-83.0) 20 69.5 (66.3-72.4) 4 69.8 (66.4-72.9) 15
Tennessee 78.1 (77.7-78.6) 41 78.8 (77.8-79.7) 44 66.7 (63.6-69.6) 40 66.9 (63.4-70.1) 45
Texas 79.0 (78.5-79.5) 26 80.9 (79.8-81.9) 31 67.7 (64.5-70.6) 24 68.6 (65.2-71.9) 31
Utah 80.8 (80.3-81.2) 4 81.4 (80.5-82.2) 24 68.7 (65.2-71.7) 8 68.8 (65.3-71.9) 27
Vermont 79.8 (79.3-80.3) 13 82.2 (81.2-83.3) 12 68.5 (65.3-71.4) 10 70.3 (67.0-73.5) 6
Virginia 78.7 (78.3-79.2) 30 81.3 (80.4-82.1) 25 67.2 (64.0-70.2) 32 69.0 (65.6-72.1) 26
Washington 79.8 (79.3-80.3) 14 82.3 (81.4-83.2) 10 68.3 (65.0-71.2) 14 70.0 (66.4-73.2) 10
West Virginia 78.0 (77.5-78.5) 44 77.9 (76.8-78.9) 50 66.2 (62.9-69.1) 47 65.5 (61.9-68.5) 51
Wisconsin 80.0 (79.6-80.5) 12 81.7 (80.8-82.5) 18 68.6 (65.4-71.5) 9 69.8 (66.3-73.0) 14
Wyoming 79.6 (78.8-80.3) 21 80.8 (79.3-82.2) 32 68.1 (64.8-71.1) 17 68.6 (64.9-71.9) 33
Washington, DC 74.6 (73.9-75.3) 51 80.6 (79.1-82.2) 34 63.9 (60.8-66.6) 51 69.1 (65.6-72.6) 24
Abbreviation: UI, uncertainty interval.
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declined in all states. The most pronounced declines were in
South Carolina, Georgia, Alaska, and New York, at higher than
a 0.85-point decrease in probability (Figure 3). In contrast, Maine
had the lowest decline of 0.32-point probability. In the United
States as a whole, there was a decline of 0.70, which was asso-
ciatedwithneonataldisorders,othernoncommunicablediseases
(includingcongenital),andalargecontributionfrominjuries,with
slight increases from mental and substance use disorders
(Figure 3).
The largest reductions in probability of death for ages 20 to
55 years were observed in New York (3.5) and California (2.5) and
the highest increases were observed in West Virginia (2.6) and
Oklahoma (2.0) (Figure 4). In 21 states, the probability of death
has actually increased from 1990 to 2016, but of these, only 5
showed an increase of greater than 10% (Kentucky, Oklahoma,
New Mexico, West Virginia, and Wyoming). Conversely, 31 states
and Washington, DC have seen decreases in the probability of
death among adults aged 20 to 55 years over the same period, but
onlyin15stateswasthatdecreasemorethan10%(NewYork,Cali-
fornia, Illinois, New Jersey, Georgia, Maryland, Florida, Nevada,
Texas, Virginia, Connecticut, North Carolina, Massachusetts,
Washington, South Carolina). Decreases in the probability of
death in US states were influenced by declines in HIV/AIDS across
allstategroups,aswellasdeclinesinroadinjuriesandneoplasms,
while increases in probability of death were influenced by in-
creased burden of drug use disorders, alcohol use disorders, and
chronic kidney disease, among others (Figure 4).
All states experienced a considerable reduction in prob-
abilities of death for ages 55 to 90 years, largely associated with
reductions in the probability of dying from cardiovascular dis-
eases (Figure 5). The highest point decline was observed in Cali-
fornia at 12.6 points, compared with lowest decline of 3.5 points
for Mississippi. These declines were somewhat offset by in-
creases in the death rates associated with cirrhosis and other
liver disease, neurological disorders, and mental and sub-
stance use disorders in all states. Hawaii was the only state in
which the probability of death was less than 65% for ages 55
to 90 years. Other notable findings include the variation in the
decline of probability of death between the 3 age groups, with
an 8.3-point decline of probability of death for ages 55 to 90
years, a 1-point decline for ages 20 to 55 years, and a 0.7-point
decline for ages 0 to 20 years.
YLLs Overall, by State, and for Washington, DC
The age-standardized YLL rates for the United States, all states,
and Washington, DC in 2016 for the top 20 causes are grouped
by 3 levels of significance (Figure 6) indicating significantly be-
lowthemean, indistinguishablefromthemean,andsignificantly
higher than the mean. The heat map shows a clear pattern of per-
formancerangingfromMinnesotatoMississippi,withsomeclear
patternsofexceptionforsomecauses.Forexample,Coloradohad
a YLL rate from self-harm significantly above the mean (760),
while Washington, DC had a YLL rate significantly lower than the
mean (306). Mississippi, West Virginia, Alabama, Oklahoma,
Kentucky, Tennessee, South Carolina, Indiana, Missouri, and
Ohio had YLLs significantly higher than the mean with a few
exceptions of causes that were indistinguishable from the
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Figure 3. Change in the Probability of Death Between Birth and Age 20 Years, 1990-2016, Reported Showing Major Causes of Death
for the United States Overall and the 50 States
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Figure 4. Change in the Probability of Death Between Ages 20 and 55 Years, 1990-2016, Reported Showing Major Causes of Death
for the United States Overall and the 50 States
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Figure 5. Change in the Probability of Death Between Ages 55 and 90 Years, 1990-2016, Reported Showing Major Causes of Death
for the United States Overall and the 50 States
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all causes higher than that of the US mean except for Alzheimer
diseases and other dementias that was significantly higher than
the mean, while Georgia had only 1 cause, drug use disorder, that
was significantly above the US mean.
Figure 6. Age-Standardized Rates of Years of Life Lost per 100 000 Persons for the 20 Leading Causes of Years of Life Lost in 2016










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2317 1215 946 781 636 860 982 393 434 341 415 526 391 301 397 293West Virginia
2664 1210 1242 638 850 736 399 344 452 552 517 452 416 418 499 323Mississippi
Significantly lower than mean US rate Indistinguishable from mean US rate Significantly higher than mean US rate 
Age-standardized rates of years of life lost per 100 000
Boxes are colored green if significantly less than the US rate (P<.05), red if significantly more than the US rate (P<.05), and yellow if not significantly different from
the US rate (P.05).
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Observed to Expected YLLs Overall, by State, and for Washington, DC
The ratio of observed YLLs to those expected, based on the SDI
for the 10 leading causes of YLLs for the United States overall,
each individual state, and Washington, DC, are shown in
Figure 7. For example, in Alabama, the stroke ratio was 1, indi-
cating that the observed rates are similar to what would be ex-
pected given the state’s SDI, whereas diabetes is observed at 2.85
times more than expected. For the United States overall, the ra-
tios of observed YLLs to those expected were 0.75 for IHD, 1.11
for lung cancer, 1.88 for chronic obstructive pulmonary dis-
ease, 0.61 for stroke, 1.19 for road injury, 1.14 for Alzheimer dis-
ease, 0.98 for self-harm, 7.17 for drugs, 0.84 for colorectal can-
cer, and 1.27 for lower respiratory tract infection. In general, most
states performed better on IHD and stroke but worse for chronic
obstructive pulmonary disease and drug use disorders. Colo-
rado had the best performance for IHD at 0.58 observed to ex-
pected ratio of YLLs, while West Virginia had the highest ob-
served to expected ratio of YLLs for drug use disorders at 14.38.
Other notable findings are the high rates in Washington, DC for
interpersonal violence, drug use disorders, HIV/AIDS, and
chronic kidney disease, given that Washington, DC has the high-
est SDI rank in the US and in the world.
Observed to Expected YLDs by State and for Washington, DC
The ratio of the YLDs observed to those expected based on SDI
for the 10 leading causes of YLDs for the United States overall, the
50 states, and Washington, DC are shown in Figure 8. Minnesota
had lower observed YLDs from low back and neck pain (0.63 ra-
tio) and migraine (0.79), but higher YLD rates from drug use dis-
orders (2.32). Most states had lower than expected YLDs from low
back and neck pain but higher rates for drug use disorders and
other musculoskeletal disorders. A notable finding is the higher
than expected rates of YLDs from depression, anxiety, and skin
diseases, and lower than expected rates from falls in most states.
Observed to Expected DALYs by State and for Washington, DC
The ratio of DALYs observed to those expected based on SDI for
the 10 leading causes of DALYs for the United States overall, the
50 states, and Washington, DC are shown in Figure 9. All states
hadlowerthanexpectedDALYratesfromIHDexceptforAlabama,
Arkansas,Kentucky,Mississippi,Oklahoma,Tennessee,andWest
Virginia. The highest observed rates of DALYs compared with ex-
pected from drug use disorders were in West Virginia at 7.77 and
in Kentucky at 7.31. Other notable findings are the higher than ex-
pected rates of drug use disorders and interpersonal violence in
Washington, DC, and the lower than expected rates of lung can-
cer in California.
Changes in Age-Standardized Summary Exposure Values
Theage-standardizedpercentchangesinsummaryexposureval-
ues for the top 10 risk factors from 1990 to 2016 are shown in
Table 7. High fasting plasma glucose increased by 76% and high
bodymassindexby53.2%,whilesmokingdeclinedby42.8%dur-
ing the same time period in the United States. There were clear
patterns in these variations by states. High fasting plasma glu-
cose increased in all states; the increase ranged from 127.2% in
Mississippi to 1.7% in Pennsylvania. Drug use increased in all
states except Arkansas, Maryland, and Oregon. Other notable
findings include reductions in high systolic blood pressure, high
total cholesterol levels, and diet low in whole grains in all states.
Leading Risk Factors for DALYs by State and for Washington, DC
The rank of risk factors by state in 2016 are shown in Figure 10.
Tobacco smoking was the leading risk factor for DALYs in the
United States and in 33 states. Alcohol and drug use were the
leading risk for DALYs for 7 states and Washington, DC, while
high BMI was the leading cause for 10 states (California, Con-
necticut, Hawaii, Illinois, Maryland, New Jersey, New York,
North Dakota, Texas, and Virginia). Another notable finding
is that diet was the third leading cause of DALYs in the United
States overall but the second in 20 states.
Discussion
This study provides a comprehensive report on the burden of
disease and its patterns in the United States and the individual
50 states from 1990 to 2016 and reveals wide disparities in bur-
den of disease at the state level. Moreover, these findings show
distinct trends in different age bands and demonstrate that im-
provement in some health outcomes, such as IHD, lung can-
cer, and neonatal preterm complications, are balanced by ris-
ing death rates from drug use disorders, chronic obstructive
pulmonary disease, self-harm, chronic kidney disease, cirrho-
sis, and hypertensive heart disease. Summary measures, such
as life expectancy, that do not differentiate the trends in differ-
ent age groups mask the heterogeneous directions for US health
status by age and state. Above and beyond the drivers of diver-
gent trends, the study reveals that there has been far greater
progress in reducing the burden of some major causes of YLLs,
such as IHD and lung cancer, but no progress in addressing some
of the leading causes of YLDs such as mental health disorders
and musculoskeletal disorders. These findings should be used
to examine the causes of health variations and to plan, de-
velop, and implement programs and policies to improve health
overall and eliminate disparities in the United States.
Mortality reversals in 21 states for adults ages 20 to 55 years
are strongly linked to the burden of substance use disorders, cir-
rhosis, and self-harm, and this study shows that the trends for
some of these conditions differ considerably across different
states. Case and Deaton have called some of these conditions
“deaths of despair” and argued that they are linked to the social
and economic status of white US adults.3 A wide range of inter-
ventions have been proposed to address substance abuse, cirrho-
sis, and self-harm. For substance abuse,28,47-49 prevention pro-
grams should account for the root causes of substance use, the
socioeconomic factors involved, and causes of relapses during
treatment.50,51 Physicians have a major role to play in addiction
control by counseling their patients who are on medication for
pain control.52-54 For cirrhosis, intervention strategies to treat
hepatitis C and decrease excessive alcohol consumption are im-
portant. For self-harm, the most promising approaches relate to
decreasingthecase-fatalityratefromsuicideattemptsbyrestrict-
ing access to lethal means; in the United States, a large share of
suicides are due to firearms.55,56 While multiple strategies are
availablefordealingwiththeseproblems,theyhavenotuntilvery
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Figure 7. Ratio of Observed Years of Life Lost (YLLs) to Expected YLLs Based on the Sodiodemographic Index (SDI) for the United States Overall,



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Ratio details: Alabama’s, stroke ratio (eg, 1.0 [observed and expected rates were similar]; diabetes [2.85 × above expected]). See Appendix Table 2 in Supplement 2
for explanation of terms.
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Figure 8. Ratio of Observed Years Lived With Disability (YLDs) to Expected YLDs Based on the Sociodemographic Index (SDI) for the United States



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































See Figure 7 caption for details. See Appendix Table 2 in Supplement 2 for explanation of terms.
US Burden of Diseases, Injuries, and Disease Risk Factors, 1990-2016 Original Investigation Research
jama.com (Reprinted) JAMA April 10, 2018 Volume 319, Number 14 1463
© 2018 American Medical Association. All rights reserved.
Figure 9. Ratio of Observed Disability-Adjusted Life-Years (DALYs) to Expected DALYs Based on the Sociodemographic Index (SDI) for the United States



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































See Figure 7 caption for details. See Appendix Table 2 in Supplement 2 for explanation of terms.
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recently garnered attention. The increases in these causes of
death have been underway for 20 years, but the US health policy
communityhasbeenslowtorecognizethisrisingsetofproblems.
This study shows that high BMI, smoking, and high fast-
ing plasma glucose are the 3 most important risk factors in the
United States, and that although smoking is decreasing, BMI
Figure 10. Ranking of Risk Factors in 2016 for the United States Overall, the 50 States, and the District of Columbia According to the Number
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and fasting plasma glucose levels are steadily increasing. These
2 risk factors pose unique challenges in the United States given
that unabated, they have the potential to change the health tra-
jectory for individuals in many states. Levels of overweight and
obesity increased during the study period. US residents need
to do more to maintain their weight or reduce it, when needed,
as well as access systems to support these intentions.57 Al-
though physical activity increased during the study period, the
levels of increase were not enough to control weight gain.8
Physical inactivity is a risk factor for many diseases, but in-
creasing activity is not enough on its own to reduce weight or
prevent weight gain.58 Obesity is associated with increased dia-
betes, cardiovascular diseases, some neoplasms, and poor
health-related quality of life. This study calls for renewed ef-
forts to control weight gain at the community level.
Several studies have reported on the effect of taxes on sug-
ary drinks or subsidies to encourage consumption of healthy
foods, although only a small fraction of obesity can be linked
to sugar-sweetened beverages.59 A comprehensive plan is
needed to address obesity because it adversely affects health
and drives use of health care resources.4,60-62 Rising BMI is driv-
ing up fasting plasma glucose levels and diabetes, and diabe-
tes increased as a cause of burden in almost all states during
the study period. Diabetes is a costly disease that consumes
approximately 4.82% of the US health care budget.4 A recent
study estimated that the cost of diabetes care increased by 6.1%
from 1996 to 2013.4 Diabetes is associated with many condi-
tions and disabilities.63 This rise in burden and its cost is note-
worthy given the projected increase in diabetes as obesity in-
creases in the United States.
This study shows that there were reductions in the death
rates from cardiovascular diseases for all age groups. This prog-
ress has been, in part, influenced by reductions in systolic blood
pressure and cholesterol, but the role of increased access to ef-
fective treatment has also been considerable.64 In fact, age-
standardizedCVDdeathrateshavedecreasedintheUnitedStates
by 32.8% over the last 20 years. The important role of treatment
in reducing death rates highlights the ongoing importance of en-
suring financial and physical access to care and the importance
of quality of care. As declines in the rate of CVD may be slowing
down, adverse trends due to the diseases of despair and adverse
risk trends may mean that historical progress in improved life ex-
pectancy may not continue in the future.
Thestrategiesfordealingwiththeremaininginequalitiesand
new threats are 3-fold: (1) address some of the key modifiable
risks, including diet; tobacco, alcohol, and drug use; insufficient
physical activity; and obesity; (2) improve access to and, more
importantly, quality of care in key areas, such as chronic kidney
disease and ongoing care for substance use disorders; and (3) ad-
dress the social determinants of health. We have previously
shown an association between socioeconomic and race/ethnicity
factors and a 60% county-level variation in life expectancy, be-
havioral and metabolic risk factors and a 74% variation, and
health care factors and a 27% variation.65 Combined, these fac-
tors are associated with 74% of overall variation. We also reported
that most of the association between socioeconomic and race/
ethnicity factors and life expectancy was mediated through be-
havioral and metabolic risk factors. Research has shown that
some environmental factors have an effect on risk factors such
as obesity and low physical activity. Low socioeconomic settings
often have an imbalance of few grocery stores and numerous fast
food options, and access to safe outdoor places spaces for rec-
reation is limited.66,67
To date, the strategies for addressing the social determi-
nants of health in the United States have been elusive. Lack
of progress and rising social inequalities should not engender
complacency. Therefore, addressing risk factors may prove to
be an important opportunity to reduce disparities and deal with
some of the challenges for improving US health. Opportuni-
ties to decrease the burden of disease through reducing to-
bacco, alcohol, drug use, blood pressure, and cholesterol; in-
creasing physical activity; and improving diet emphasize that
the United States should invest more in prevention that tar-
gets these risks. To increase the likelihood of prevention to suc-
ceed, it has to be a priority for all stakeholders—physicians,
nurses, hospital systems, policy makers, health insurance com-
panies, patients and their families, and advocacy groups.
This study showed a wide range of challenges encountered
by different states and by some counties within states. Given the
diversityofrisks,communities,andworkplacesthereisnosimple
menu of effective programs for risk reduction. Indeed, local ex-
perimentation to determine what works in a given community
is likely to be necessary. There is a need to change strategies of
funding and evaluation of innovative interventions and policies,
and independent evaluation of whether these efforts work or not
should be documented. To succeed, these innovative programs
should forge a connection between health care provision and
progress for individuals and communities in health outcomes.
The notion of accountability should be broadened beyond pro-
viding high-quality care to encompass achieving risk reduction
in partnership with patients and communities.
The interpersonal violence burden in the United States has
to be properly addressed, although declines have been ob-
served: the age-standardized death rate decreased 32.43% from
1990 to 2016 in the United States. However, self-harm by fire-
arm accounted for 6.39 deaths per 100 000 persons in the
United States in 2016, and physical violence by firearm ac-
counted for 3.98 deaths per 100 000 persons. There is evi-
dence that gun control achieved through background checks
reduces homicide and suicide.68-72 Previous studies reported
success in reducing the burden of gun deaths through policy
changes in Brazil and other countries.71 Indeed, enforcing gun
control policies has proven effective in reducing mortality in
a variety of contexts. There is a need for comprehensive stud-
ies of the epidemiology of gun violence in the United States
to inform the ongoing gun control debate.
Age-standardized death rates due to alcohol increased by
17.50% from 1990 to 2016 in the United States, and alcohol use
disorders accounted for 2.89 deaths per 100 000 persons in 2016.
Previousstudieshaveshownthatalcoholconsumptionandbinge
drinking have increased in the United States, especially among
females.6,73 Alcohol is a major risk factor for burden in the United
States10 and is associated with adverse outcomes including sexu-
ally transmitted diseases, violence, and accidents.16 Traffic in-
juries have received a considerable amount of attention, but the
true burden of alcohol is much bigger and goes beyond driving
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while intoxicated. Programs to educate US residents about the
true harms of excessive drinking are needed.
Many of the risk factors that contribute to the disparities
in burden are amenable to medical treatment within the con-
text of supportive behavioral and lifestyle changes. For ex-
ample, many cardiovascular risk factors, such as high blood
pressure and high cholesterol levels, can now be treated more
effectively with early detection and proper follow-up. Safe, ef-
fective, and affordable antihypertensive medications are now
widely available, often as generic preparations, especially at
discount pharmacies, and in many cases, without the need for
health insurance for medications. The Affordable Care Act
(ACA) allows for the expansion of insurance coverage, which
ultimately increases access to care. Indeed, the ACA expan-
sion of Medicaid coverage in participating states to all nonel-
derly adults with incomes below 133% of the federal poverty
level provides an opportunity for early detection and fol-
low-up of some of the main health risk factors. However, many
US residents do not have health insurance, even after the ACA
was introduced, and hence have little access to medical diag-
nosis and treatment. Therefore, expanding health coverage for
certain conditions and medications should be considered and
adopted to reduce burden.
This study showed that the United States overall and many
individual states have made progress in reducing mortality but
have had limited success in reducing disability. For instance,
the burden of drug use disorders in total DALYs increased in
the United States during the study period by 61.4% and ac-
counted for about 3.81 million DALYs in 2016, depressive dis-
orders increased 17.32% and accounted for 2.72 million DALYs,
and anxiety disorders increased by 16.7% and accounted for
approximately 1.76 million DALYs in 2016. These findings point
to an urgent need to address mental health and drug use dis-
orders in the United States. There is a need for improved ac-
cess to quality mental health care and screening to improve
outcomes, as well as programs to prevent mental disorders and
promote mental health.
As the US population ages, the burden of musculoskel-
etal disorders will increase. More US residents have neck and
back pain, and the incidence of falls is increasing. Musculo-
skeletal disorders are associated with a high medical cost.4 Pre-
ventive measures to reduce the burden of these risk factors in
all stages of life are urgently needed. Programs for avoiding
harm and injuries at work among both younger and older ages
are needed. The programs should include prevention of falls
in the older population through examining the risk factors that
lead to falls among adults. Screening tools and interventions
to address this burden should be implemented.
The results of GBD 2016 have shown that occupational risks
and air pollution were the 9th and 10th leading causes for
DALYs. Although the findings show reductions in attribut-
able burden from 1990 to 2016, occupational risks still ac-
count for 948.75 DALYS per 100 000 persons, and air pollu-
tion accounts for 584.97 DALYs per 100 000 persons—large
numbers in the United States. Indeed, renewed efforts to re-
duce the burden of environmental and occupational risks are
needed to ensure continued progress in reducing their effect
on health in the United States.
Several studies have shown that poor diet is a major chal-
lenge in the United States, and little improvement has oc-
curred over the past decades. US residents are not consuming
a healthy diet; they tend to consume more calories than
needed, and composition is not ideal.49,62 Some recent stud-
ies have shown modest improvement in certain aspects of US
diet, especially decreases in consumption of sugary drinks. The
United States needs a comprehensive program to improve di-
etary intake at national and local levels. This program should
offer financial incentives and disincentives for more vs less
healthful food products by agriculture producers, food manu-
facturers, and retailers, as well as for choices by consumers.
This effort should also implement comprehensive wellness pro-
grams in schools, workplaces, and government offices, and in-
form the public of the importance of a healthful diet.
Limitations
Given the scope of this analysis, this study has several impor-
tant limitations. The overall limitations of the GBD methods,
as noted in other publications, apply to the US analysis. First,
the accuracy of the estimates depends on the availability of data
by time period and state. Second, it is challenging to separate
measurement error from variation in disease occurrence. GBD
corrects for known bias from nonreference methods or case
definitions, but often has to rely on sparse data at the state level
to make those adjustments. Third, GBD applies garbage code
redistribution for 13% of causes of deaths in the United States;
this ranged from 8.4% in South Dakota to 21.3% in Alabama.
Therefore, the causes of death may not match those in other
publications but are more robust because they control for the
between-states variation in the prevalence of garbage codes.
Fourth, GBD methods adjust for hospital admissions using a
large nonrepresentative source of medical claims data. The gen-
eralizability of claims data, the use of primary diagnosis only
or all diagnostic fields, and the trends of claims data have been
questioned.13 Also, there may be considerable interstate varia-
tion in how diseases are treated between inpatient and out-
patient settings. GBD methods adjust for such potential bi-
ases by using a covariate on claims and hospital admissions data
to correct for systematic error. Fifth, GBD includes risk-
outcome pairs that meet the World Cancer Research Fund cri-
teria of causality. However, some risk-outcome pairs might not
meet criteria that develop as evidence from new studies is pub-
lished. Sixth, there is limited information on dietary intake at
the state level. The Behavioral Risk Factors Surveillance Sys-
tem has 6 dietary questions attempting to capture fruit and veg-
etable consumption. Therefore, GBD 2016 used commercial
sales data to adjust estimates of dietary intake. Seventh, some
of the data used in the analyses have a lower quality and con-
sistency across states and age groups. GBD 2016 reports 95%
UIs to show the effect of this limitation on the estimates. Eighth,
the study reports disparities between states but does not ex-
amine the within-state variations of burden, which could be
substantial, especially in large states. Ninth, claims data were
only available through 2012 at the time of these analyses. Ad-
ditionally, this study does not report the burden of the social
determinants of health; it focuses only on behavioral, envi-
ronmental, and metabolic risks.
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Conclusions
There are wide differences in the burden of disease at the
state level. Specific diseases and risk factors, such as drug
use disorders, high BMI, poor diet, high fasting plasma
glucose level, and alcohol use disorders are increasing and
warrant increased attention. These data can be used to
inform national health priorities for research, clinical care,
and policy.
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